Brief: Ers Genomics and Evolva sign license agreement on CRISPR-Cas9 genome editing patents

EvoNext Holdings SA

27/10/2016 06:04

Oct 27 (Reuters) - Evolva Holding SA  EVE.S : 
    * Ers Genomics and Evolva sign license agreement on CRISPR-Cas9 genome editing patents for 
industrial applications 
 
Source text for Eikon:  ID:nTENv8udsa  
Further company coverage:  EVE.S  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))